Additionally, intravenous transplantation of ACE2-mesenchymal stem cells (MSCs), blocking of FcR with immunoglobulin (IVIG), and systemic anti-inflammatory drugs to reduce cytokine storm are also potential therapeutic strategies for severe COVID-19 [61,79]. This evidence concerns the gene ACE2 and COVID-19.